# TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

> **NCT07480785** · NA · RECRUITING · sponsor: **Zhejiang University** · enrollment: 780 (estimated)

## Conditions studied

- Uterine Fibroids (Leiomyoma)
- Ovarian Tumors
- Gallstones

## Interventions

- **DEVICE:** transcutaneous electrical acupoint stimulation
- **DEVICE:** Sham transcutaneous electrical acupoint stimulation
- **DRUG:** triple antiemetic drugs

## Key facts

- **NCT ID:** NCT07480785
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-16
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 780 (ESTIMATED)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07480785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07480785, "TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07480785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*